These Stocks Are Moving the Most Today: Micron, Intra-Cellular Therapies, and More
Nvidia pushes back on new artificial-intelligence regulations, Moderna issues weak revenue guidance, and Intra-Cellular Therapies is being acquired by Johnson & Johnson for nearly $15 billion.